There are 321 papers on osteosarcopenia in aging research: 23 trials and 156 observational studies in people, 19 in animals, 1 in cells, 109 reviews.
321 papers study it87 more mention it308 findings
10 new papers in 30 daysSee all 408 papers on osteosarcopenia
At a glance
Osteosarcopenia is linked with higher mortality, falls, fractures, and functional impairment in observational studies of Chilean community-dwelling older adults. Studies in patients undergoing hemodialysis also associate it with higher mortality and fracture risk, while studies in older adults link it with worse health-related quality of life.
308 findings in 160 papers from 2017 to 2026, 30 of them since April 2026
“osteosarcopenia (aHR 1.33; 95% CI 1.09-1.62) were independently associated with incident AF”
- Human trial23
- Humans156
- Animals19
- Cells1
- In silico4
Interventions
3Proper nutrition
downin humans1
1 study
Proper nutrition
downin humans1
Proper nutrition prevents osteosarcopenia in humans.
“Regular physical exercise and proper nutrition are fundamental for osteosarcopenia prevention.”
Review
Prevention of Hip Fractures in the Elderly. A Public Health Problem. II. Interventions
Revista espanola de cirugia ortopedica y traumatologia
Physical exercise
downin humans1
1 study
Physical exercise
downin humans1
Physical exercise prevents osteosarcopenia in humans.
“Regular physical exercise and proper nutrition are fundamental for osteosarcopenia prevention.”
Review
Prevention of Hip Fractures in the Elderly. A Public Health Problem. II. Interventions
Revista espanola de cirugia ortopedica y traumatologia
Metformin
no changein humans1
1 study
Metformin
no changein humans1
Metformin showed no clear effect on osteosarcopenia in humans (type 2 diabetes).
“Insulin resistance, duration of T2D, glycaemic control, and metformin, sulfonylurea and insulin use were not shown to be significant risk factors.”
Reviewtype 2 diabetes
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Effects
25Physical function
downin humans4
4 studies
Physical function
downin humans4
Osteosarcopenia is linked with worse physical function in community-dwelling elderly Chinese (P < 0.01-P < 0.001).
“Regarding physical function, individuals with osteosarcopenia exhibited significantly poorer physical performance, including longer times in the five-repetition sit-to-stand test, slower TUG times, reduced handgrip strength, lower SPPB scores, and slower gait speeds”
Humansin community-dwelling elderly Chinesen = 519
Journal of endocrinological investigation
Osteosarcopenia is linked with worse physical function in humans.
“Osteosarcopenic women showed impaired physical function and lower bone density”
Humansfemalesn = 397
Archives of osteoporosis
Osteosarcopenia is linked with worse physical function in humans (acute stroke).
“modified Rankin Scale, Berg Balance Scale, modified Barthel Index, Functional Ambulation Category, and grip strength were significantly lower in patients with osteosarcopenia.”
Humansacute stroken = 224
American journal of physical medicine & rehabilitation
Osteosarcopenia impairs physical function in humans.
“Its clinical manifestations include reduced physical performance”
Review
Research advances in crosstalk between muscle and bone in osteosarcopenia (Review)
Experimental and therapeutic medicine
Activities of daily living
downin humans3
3 studies
Activities of daily living
downin humans3
Osteosarcopenia is linked with worse activities of daily living in humans.
“Osteosarcopenia patients had worse outcomes, including lower ADL, higher ODI, and more re-fractures and falls.”
Humansone year
Aging clinical and experimental research
Osteosarcopenia is linked with lower activities of daily living in elderly patients with osteoporosis.
“The osteosarcopenic group demonstrated poorer bone and muscle quality and quantity, with greater risks of major osteoporotic-related fractures, hip fractures, and falls, as well as significantly decreased ADL than other groups.”
Humansin elderly patients with osteoporosis
Aging clinical and experimental research
Osteosarcopenia is linked with worse activities of daily living in humans (compared to those without) (β 0.110, 95% CI 0.029, 0.192).
“Participants with osteosarcopenia had worsening ADL of 0.110 (estimated β coefficient 0.110, 95% CI 0.029, 0.192)”
Humanscompared to those withoutn = 8,888
Journal of the American Medical Directors Association
Mortality
upin humans3
3 studies
Mortality
upin humans3
Osteosarcopenia is linked with higher mortality in humans.
“Osteosarcopenia, probable sarcopenia and osteoporosis were all associated with increased risk of any fracture and mortality compared to the reference group.”
Humans19.1 yearsn = 2,506
Aging clinical and experimental research
Osteosarcopenia is linked with higher mortality in patients who underwent vertebroplasty after osteoporotic vertebral compression fracture (2.8-fold).
“but it increased mortality 2.8-fold for those who underwent vertebroplasty after vertebral fracture”
Humansin patients who underwent vertebroplasty after osteoporotic vertebral compression fracturen = 104
Acta orthopaedica et traumatologica turcica
Osteosarcopenia increases mortality in patients with hip fractures.
“Increasing amount of evidence suggests that osteosarcopenia in patients with hip fractures contributes to higher rates of mortality and complications.”
Reviewin patients with hip fractures
Osteosarcopenia and geriatric hip fractures: Current concepts
World journal of orthopedics
Falls
no changein humans2RR 1.15
2 studies
Falls
no changein humans2RR 1.15
Osteosarcopenia was not clearly linked with falls in humans (compared with either osteopenia/osteoporosis or sarcopenia alone).
“falls and fracture risk were not different for osteosarcopenia compared with either condition alone (all p > .05)”
Humanscompared with either osteopenia/osteoporosis or sarcopenia alone2 yearsmales
The journals of gerontology. Series A, Biological sciences and medical sciences
Osteosarcopenia showed no clear effect on falls in humans (RR 1.15 (vs low BMD); RR 1.06 (vs sarcopenia)).
“Falls risk did not differ for osteosarcopenia compared to low BMD (RR 1.15; 95% CI 0.44, 2.97; k = 3; I2 = 72.9%) or sarcopenia (RR 1.06; 95% CI 0.70, 1.59; k = 3; I2 = 1.1%)”
Review
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Bone fracture
no changein humans2RR 1.22
2 studies
Bone fracture
no changein humans2RR 1.22
Osteosarcopenia was not clearly linked with bone fracture in humans (compared with either osteopenia/osteoporosis or sarcopenia alone).
“falls and fracture risk were not different for osteosarcopenia compared with either condition alone (all p > .05)”
Humanscompared with either osteopenia/osteoporosis or sarcopenia alone6 ± 2 yearsmales
The journals of gerontology. Series A, Biological sciences and medical sciences
Osteosarcopenia showed no clear effect on bone fracture in humans (compared to low BMD) (RR 1.22; 95% CI 0.96, 1.56).
“Osteosarcopenia was associated with similar fracture risk as low BMD (RR 1.22; 95% CI 0.96, 1.56; k = 6, I2 = 0%)”
Reviewcompared to low BMD
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Frailty
no changein humans1upin reviews1
2 studies
Frailty
no changein humans1upin reviews1
Osteosarcopenia was not clearly linked with frailty in humans.
“Osteosarcopenia was not associated with frailty for both males and females.”
Humansn = 8,888
Journal of the American Medical Directors Association
Osteosarcopenia increases frailty in individuals with concurrent bone and muscle loss.
“negative outcomes such as falls, fractures, loss of function, frailty, and mortality increase”
Reviewin individuals with concurrent bone and muscle loss
Osteosarcopenia: where bone, muscle, and fat collide
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Home discharge
no changein humans1OR 0.525
1 study
Home discharge
no changein humans1OR 0.525
Osteosarcopenia was not clearly linked with home discharge in humans (undergoing rehabilitation) (OR 0.525, 95% CI 0.126-2.189).
“discharge to home (OR: 0.525; 95% CI: 0.126-2.189)”
Humansundergoing rehabilitationn = 184
Journal of frailty, sarcopenia and falls
Functional Independence Measure
no changein humans1
1 study
Functional Independence Measure
no changein humans1
Osteosarcopenia was not clearly linked with Functional Independence Measure in humans (undergoing rehabilitation) (β = 0.058, 95% CI -2.518-8.489).
“Osteosarcopenia did not reach a statistically significant association with FIM at discharge (95% confidence interval [CI]: -2.518-8.489; β, 0.058)”
Humansundergoing rehabilitationn = 184
Journal of frailty, sarcopenia and falls
Total intrinsic capacity
downin humans1
1 study
Total intrinsic capacity
downin humans1
Osteosarcopenia is linked with lower total intrinsic capacity in humans (76.6 ± 1.1 points vs 83.7 ± 0.5 points, p < .001).
“Older adults with osteosarcopenia exhibited lower total IC (76.6 ± 1.1 points) than those without musculoskeletal disorders (83.7 ± 0.5 points; p < .001)”
Humansn = 1,142
The journals of gerontology. Series A, Biological sciences and medical sciences
miR-206-3p
downin humans1
1 study
miR-206-3p
downin humans1
Osteosarcopenia is linked with lower miR-206-3p in osteosarcopenia vs controls (P < 0.001).
“miR-206-3p was significantly downregulated in both tissues of the osteosarcopenia group (P < 0.001)”
Humansin osteosarcopenia vs controlsmusculoskeletal tissuen = 158
The expression characteristics of miR-206-3p in musculoskeletal tissue and its clinical significance
Journal of orthopaedic surgery and research
All 25Fewer
Upstream
8SNUPN
downin silico1
1 study
SNUPN
downin silico1
SNUPN protects against osteosarcopenia in silico.
“MGP, CTSS, and SNUPN were recognized as protective factors”
In silico
The journals of gerontology. Series A, Biological sciences and medical sciences
CTSS
downin silico1
1 study
CTSS
downin silico1
CTSS protects against osteosarcopenia in silico.
“MGP, CTSS, and SNUPN were recognized as protective factors”
In silico
The journals of gerontology. Series A, Biological sciences and medical sciences
MGP
downin silico1
1 study
MGP
downin silico1
MGP protects against osteosarcopenia in silico.
“MGP, CTSS, and SNUPN were recognized as protective factors”
In silico
The journals of gerontology. Series A, Biological sciences and medical sciences
epigenetic dysregulation
upin reviews1
1 study
epigenetic dysregulation
upin reviews1
epigenetic dysregulation induces osteosarcopenia.
“Emerging evidence implicates cellular senescence and epigenetic dysregulation as convergent mechanisms driving osteosarcopenia.”
Review
Aging and disease
MICRORNA-672
downin reviews1
1 study
MICRORNA-672
downin reviews1
MICRORNA-672 protects against osteosarcopenia (when expressed in the disease).
“microRNA-672 stands out for its ability to protect skeletal muscle and bone when expressed in the disease”
Reviewwhen expressed in the diseaseskeletal muscle and bone
MicroRNAs and their Modulatory Effect on the Hallmarks of Osteosarcopenia
Current osteoporosis reports
FOXO1/4
is required forin mice1
1 study
FOXO1/4
is required forin mice1
FOXO1/4 is required for osteosarcopenia in mice.
“These phenotypes are almost reversed by additional knocking out of Foxo1/4”
Animalsfor the phenotypes of skeletal muscle Akt1/2 knockout mice, shown by additional Foxo1/4 knockoutskeletal muscle
Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice
Nature communications
Telomere length
no changein humans1RR 1
1 study
Telomere length
no changein humans1RR 1
Telomere length was not clearly linked with osteosarcopenia in humans (EWGSOP2 criteria; per SD increase in telomere length) (RR 1.00, 95% CI 0.82–1.23 per SD increase).
“Baseline telomere length was not associated with osteosarcopenia by EWGSOP2”
HumansEWGSOP2 criteria; per SD increase in telomere lengthleukocyteMean 8.82 years after baseline53% mensn = 20,400
Bone
Lipid profile
no changein humans1
1 study
Lipid profile
no changein humans1
Lipid profile was not clearly linked with osteosarcopenia in humans.
“No associations were detected between the lipid profiles and osteosarcopenia.”
Humans
Calcified tissue international
Associations
159Mortality
upin humans26HR 1.45–3.74
26 studies
Mortality
upin humans26HR 1.45–3.74
Osteosarcopenia predicts mortality in humans (undergoing endovascular aneurysm repair (EVAR)) (HR 3.09, 95% CI 1.44-6.65, P = .004).
“Multivariable analysis identified osteosarcopenia as a potent independent predictor of all-cause mortality (hazard ratio [HR], 3.09; 95% confidence interval [CI], 1.44-6.65; P = .004)”
Humansundergoing endovascular aneurysm repair (EVAR)median follow-up of 5.0 (2.8, 6.8) yearsn = 240
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
Osteosarcopenia is linked with a higher risk of mortality in humans (HR (95% CI)=1.96 (1.02-3.77)).
“osteosarcopenia-but not osteopenia/osteoporosis-was associated with a higher risk of mortality compared to those without musculoskeletal disorders [HR (95% CI)=1.96 (1.02-3.77); p = .045]”
Humansmedian 6.2-yearn = 1,142
The journals of gerontology. Series A, Biological sciences and medical sciences
Osteosarcopenia is linked with a higher risk of mortality in humans (cirrhosis) (OR = 2.739, p = 0.009).
“OS conferred the highest adjusted mortality risk (OR = 2.739, p = 0.009), followed by SP (OR = 2.278, p = 0.015) and OP (OR = 1.958, p = 0.036).”
Humanscirrhosisn = 100
Journal of clinical medicine
Osteosarcopenia is linked with a higher risk of mortality in humans (EWGSOP2 definition, MBMDD cohort) (HR: 2.05, 95%CI: 1.91-2.19).
“osteosarcopenia (EWGSOP2: MBMDD: HR: 2.05, 95%CI: 1.91-2.19”
HumansEWGSOP2 definition, MBMDD cohort
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Osteosarcopenia is linked with a higher risk of mortality in humans (post-TAVI) (HR 2.09, P=0.0002).
“The Cox proportional hazards model revealed osteosarcopenia as a significant risk factor for late death (hazard ratio, 2.09; P=0.0002).”
Humanspost-TAVIn = 490
Circulation reports
Osteosarcopenia is linked with a higher risk of mortality in-hospitalized with COVID-19 (HR 1.73 (1.00-3.01)).
“In the Cox proportional hazards models, osteosarcopenia and its parameters increase the risk of COVID-mortality [Osteosarcopenia: HRadjusment:1.73(1.00-3.01)”
Humansin-hospitalized with COVID-192442 person-daysn = 297
Journal of diabetes and metabolic disorders
Osteosarcopenia is associated with mortality in humans following TAVR (OR 3.18, 95% CI 1.54-6.57).
“Osteosarcopenia, but not low VBD or PMA alone, was independently associated with 1-year mortality (odds ratio [OR], 3.18; 95% CI, 1.54-6.57)”
Humansfollowing TAVR1 yearn = 605
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement
JAMA cardiology
Osteosarcopenia is linked with a higher risk of mortality in humans (patients undergoing hemodialysis) (HR 2.13, 95% CI 1.23–3.68).
“osteosarcopenia (hazard ratio 2.13; 95% confidence interval, 1.23-3.68) showed a higher risk of all-cause mortality than the robust group”
Humanspatients undergoing hemodialysisn = 328
Journal of bone and mineral metabolism
Osteosarcopenia is linked with a higher risk of mortality in humans (HRadj 1.91 [1.21-3.04]).
“and mortality (HRadj 1.91 [1.21-3.04])”
Humans10 yearsfemales
Calcified tissue international
Osteosarcopenia is linked with a higher risk of mortality in patients undergoing hemodialysis (HR=3.74, 95% CI: 1.172-11.938).
“osteosarcopenia was independently associated with all-cause mortality (HR=3.74, 95% CI: 1.172-11.938)”
Humansin patients undergoing hemodialysis35.15 ± 15.37 monthsn = 103
Sarcopenia and osteosarcopenia among patients undergoing hemodialysis
Frontiers in endocrinology
All 26Fewer
Bone fracture
upin humans16RR 2.12
16 studies
Bone fracture
upin humans16RR 2.12
Osteosarcopenia is linked with a higher risk of bone fracture in humans.
“Osteosarcopenia, probable sarcopenia and osteoporosis were all associated with increased risk of any fracture and mortality compared to the reference group.”
Humans19.1 yearsn = 2,506
Aging clinical and experimental research
Osteosarcopenia is linked with a higher risk of bone fracture in elderly patients with osteoporosis.
“greater risks of major osteoporotic-related fractures, hip fractures, and falls”
Humansin elderly patients with osteoporosis
Aging clinical and experimental research
Osteosarcopenia is linked with a higher risk of bone fracture in humans.
“Only osteosarcopenia was associated with an increased OR for fracture.”
Humans
Annals of geriatric medicine and research
Osteosarcopenia is linked with a higher risk of bone fracture in humans (patients undergoing hemodialysis).
“Similar results were observed for the risk of fractures in patients with osteosarcopenia.”
Humanspatients undergoing hemodialysisn = 328
Journal of bone and mineral metabolism
Osteosarcopenia is linked with a higher risk of bone fracture in humans (compared to males without osteopenia/osteoporosis or sarcopenia) (aOR 2.60, 95% CI 1.14, 5.91).
“and aOR 2.60, 95% CI 1.14, 5.91, respectively] compared to males without osteopenia/osteoporosis or sarcopenia.”
Humanscompared to males without osteopenia/osteoporosis or sarcopeniamalesn = 8,888
Journal of the American Medical Directors Association
Osteosarcopenia is associated with bone fracture in humans (Chilean community-dwelling older adults).
“Falls, fractures, and functional impairment were significantly more frequent in osteosarcopenic patients.”
HumansChilean community-dwelling older adults68.5% femalesn = 1,119
Osteosarcopenia Predicts Falls, Fractures, and Mortality in Chilean Community-Dwelling Older Adults
Journal of the American Medical Directors Association
Osteosarcopenia is associated with bone fracture in humans (severe sarcopenia classification) (ORs from 3.86 to 4.38, P < .05).
“and fractures (ORs from 3.86 to 4.38; P < .05 for all) when employing the EWGSOP2 and FNIH definitions, respectively.”
Humanssevere sarcopenia classification
Journal of the American Medical Directors Association
Osteosarcopenia is linked with a higher risk of bone fracture in humans (compared with men with neither osteopenia/osteoporosis nor sarcopenia) (HR 1.87 (95% CI 1.07 to 3.26)).
“fracture risk (hazard ratio: 1.87; 95% CI: 1.07 to 3.26) compared with men with neither osteopenia/osteoporosis nor sarcopenia”
Humanscompared with men with neither osteopenia/osteoporosis nor sarcopenia6 ± 2 yearsmales
The journals of gerontology. Series A, Biological sciences and medical sciences
Osteosarcopenia raises the risk of bone fracture in humans.
“It is correlated with an increased risk of falls, fractures, disability, and mortality.”
Review
Health science reports
Osteosarcopenia raises the risk of bone fracture in humans (compared to sarcopenia alone) (RR 2.12; 95% CI 1.42, 3.15).
“but higher risk than sarcopenia (RR 2.12; 95% CI 1.42, 3.15; k = 5; I2 = 0%)”
Reviewcompared to sarcopenia alone
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
All 16Fewer
Falls
upin humans12upin reviews1
13 studies
Falls
upin humans12upin reviews1
Osteosarcopenia is associated with falls in humans.
“Osteosarcopenia patients had worse outcomes, including lower ADL, higher ODI, and more re-fractures and falls.”
Humansone year
Aging clinical and experimental research
Osteosarcopenia is linked with a higher risk of falls in elderly patients with osteoporosis.
“greater risks of major osteoporotic-related fractures, hip fractures, and falls”
Humansin elderly patients with osteoporosis
Aging clinical and experimental research
Osteosarcopenia is linked with a higher risk of falls in humans (compared to males without osteopenia/osteoporosis or sarcopenia) (aOR 1.90, 95% CI 1.15, 3.14).
“Osteosarcopenia was significantly associated with incident falls and fractures in males [adjusted odds ratio (aOR), 1.90, 95% CI 1.15, 3.14”
Humanscompared to males without osteopenia/osteoporosis or sarcopeniamalesn = 8,888
Journal of the American Medical Directors Association
Osteosarcopenia is linked with a higher risk of falls in patients with rheumatoid arthritis (3.32-fold (95%CI: 1.01-10.9)).
“The hazard ratio of falls was significantly increased in SP + OP+, by 3.32-fold (95%CI: 1.01-10.9)”
Humansin patients with rheumatoid arthritisn = 100
Osteosarcopenia synergistically increases the risk of falls in patients with rheumatoid arthritis
Osteoporosis and sarcopenia
Osteosarcopenia is associated with falls in humans (Chilean community-dwelling older adults).
“Falls, fractures, and functional impairment were significantly more frequent in osteosarcopenic patients.”
HumansChilean community-dwelling older adults68.5% femalesn = 1,119
Osteosarcopenia Predicts Falls, Fractures, and Mortality in Chilean Community-Dwelling Older Adults
Journal of the American Medical Directors Association
Osteosarcopenia is associated with falls in humans (severe sarcopenia classification) (ORs from 2.83 to 3.63, P < .05).
“osteosarcopenia (using the severe sarcopenia classification) conferred an increased rate of falls [odds ratios (ORs) from 2.83 to 3.63; P < .05 for all]”
Humanssevere sarcopenia classification
Journal of the American Medical Directors Association
Osteosarcopenia is linked with a higher risk of falls in humans (compared with men with neither osteopenia/osteoporosis nor sarcopenia) (IRR 1.41 (95% CI 1.02 to 1.95)).
“Men with osteosarcopenia had significantly increased fall (incidence rate ratio: 1.41; 95% confidence interval [CI]: 1.02 to 1.95)”
Humanscompared with men with neither osteopenia/osteoporosis nor sarcopenia2 yearsmales
The journals of gerontology. Series A, Biological sciences and medical sciences
Osteosarcopenia is associated with falls in humans (type 2 diabetes).
“OS may be associated with falls and leg fractures in T2D.”
Reviewtype 2 diabetes
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Osteosarcopenia raises the risk of falls in humans.
“It is correlated with an increased risk of falls, fractures, disability, and mortality.”
Review
Health science reports
Osteosarcopenia raises the risk of falls in humans.
“Osteosarcopenia significantly raises the risk of falls, fractures, disability, and death.”
Review
Why Osteosarcopenia Matters: Clinical and Investigative Implications
European journal of clinical investigation
All 13Fewer
Frailty
upin humans13OR 2.33–26.15
13 studies
Frailty
upin humans13OR 2.33–26.15
Osteosarcopenia is associated with frailty in humans.
“OS was associated with worse cognitive scores, chair stand test, nutritional status, and frailty (all p < 0.05).”
Humans
Bratislavské lekárske listy/Bratislava medical journal
Frailty is associated with osteosarcopenia in humans (OR = 3.38; 95% CI: 1.56–7.33; p = 0.002).
“OSP was independently associated with living with frailty (CFS ≥ 4) after adjusting for age, BMI, chronic renal disease (CRD), number of medications, malnutrition, arrhythmia, Katz Activities of Daily Living (ADL) scores, Lawton Instrumental ADL scores, and depression, serum 25-OH-D3 (OR = 3.38; 95% CI: 1.56–7.33; p = 0.002).”
Humansmalesn = 234
Frailty and osteosarcopenia in older men: a hidden vulnerability
BMC geriatrics
Osteosarcopenia is linked with a higher risk of frailty in humans (versus non-osteosarcopenia) (OR = 9.53, 95%CI 2.53-35.92).
“Osteosarcopenia (versus non-osteosarcopenia) was associated with frailty irrespective of the definition used: EWGSOP2: OR = 9.53, 95%CI 2.53-35.92”
Humansversus non-osteosarcopeniamedian: 4.8 yearsn = 143
Aging clinical and experimental research
Osteosarcopenia is associated with frailty in humans (OR 3.324, 95% CI 1.308-8.448).
“Only osteosarcopenia was associated with frailty (odds ratio 3.324, 95% confidence interval 1.308-8.448).”
Humans
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
Osteosarcopenia is associated with frailty in humans (coexisting sarcopenia and osteoporosis) (OR 26.15, 95% CI 3.13, 218.76, P = 0.003).
“The likelihood of being frail was substantially higher in the presence of coexisting SP and OP (OR 26.15, 95% CI 3.13, 218.76; P = 0.003)”
Humanscoexisting sarcopenia and osteoporosisn = 405
Journal of cachexia, sarcopenia and muscle
Osteosarcopenia is associated with frailty in humans (Kaigo-Yobo compared with normal, osteopenia-only and sarcopenia-only groups) (Kaigo-Yobo 3.0 (95% CI: 2.6-3.4) in osteosarcopenia group).
“were statistically significantly higher in the osteosarcopenia group compared the other groups”
HumansKaigo-Yobo compared with normal, osteopenia-only and sarcopenia-only groupsn = 885
Disability, Frailty and Depression in the community-dwelling older adults with Osteosarcopenia
BMC geriatrics
Osteosarcopenia is associated with frailty in humans (cross-sectional analysis, modified Fried criteria) (β = 1.1, 95% CI 0.86-1.4).
“Osteosarcopenia (β = 1.1, 95% CI 0.86-1.4) and sarcopenia (β = 1.1, 95% CI 0.90-1.4) were significantly associated with frailty”
Humanscross-sectional analysis, modified Fried criterian = 230
Nutrition Mediates the Relationship between Osteosarcopenia and Frailty: A Pathway Analysis
Nutrients
Osteosarcopenia is linked with a higher risk of frailty in humans (compared with osteoporosis alone) (OR 2.33; 95% CI 1.13-4.80; P = 0.028).
“Patients in the osteosarcopenia group had a greater risk of frailty than did those in the osteoporosis alone group (odds ratio 2.33; 95% confidence interval, 1.13-4.80, P = 0.028).”
Humanscompared with osteoporosis alonefemales
PloS one
Osteosarcopenia is associated with frailty in humans.
“Osteosarcopenia is associated with a higher risk of adverse outcomes, such as falls, fractures, depression, and frailty, and consequently with mortality.”
Review
Osteosarcopenia Revisited: From Mechanisms to Management
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Osteosarcopenia is associated with frailty in older adults.
“associated with falls, fractures, frailty, disability, and mortality”
Reviewin older adults
Metabolites
All 13Fewer
Body mass index
downin humans7upin humans1OR 0.411–0.738
8 studies
Body mass index
downin humans7upin humans1OR 0.411–0.738
Body mass index is associated with osteosarcopenia in humans (Older Vietnamese outpatients; multivariable analysis) (OR 0.57 per 1 kg/m2 increase, 95% CI 0.50–0.65).
“lower BMI (per 1 kg/m2 increase; OR 0.57, 95% CI 0.50-0.65)”
HumansOlder Vietnamese outpatients; multivariable analysisn = 389
PloS one
Body mass index predicts osteosarcopenia in older adults with type 2 diabetes mellitus.
“Univariable Firth’s penalized logistic regression identified low body mass index and a lower phase angle as independent predictors of osteosarcopenia.”
Humansin older adults with type 2 diabetes mellitusn = 147
Diabetology
Body mass index is associated with osteosarcopenia in humans after adjustment for age and confounders (p <= 0.013).
“higher stride length CV, and lower body mass index (BMI) were each independently associated with osteosarcopenia (all p ≤ 0.013).”
Humansafter adjustment for age and confoundersfemalesn = 190
BMC geriatrics
Body mass index is linked with a lower risk of osteosarcopenia in T2DM patients aged ≥ 40 years (OR = 0.56, 95% CI: 0.53-0.59).
“Higher BMI served as a protective factor (OR = 0.56, 95% CI: 0.53-0.59).”
Humansin T2DM patients aged ≥ 40 yearsn = 5,412
Frontiers in endocrinology
Body mass index is linked with a lower risk of osteosarcopenia in humans (OR = 0.738, 95% CI: 0.703-0.775).
“and BMI (OR = 0.738, 95% CI: 0.703-0.775).”
Humansn = 1,897
Aging clinical and experimental research
Body mass index is linked with a lower risk of osteosarcopenia in humans (postmenopausal women) (OR = 0.411, 95% CI: 0.319-0.529).
“identified as an independent protective factor for sarcopenia alone (OR = 0.592, 95% CI: 0.455-0.769) or osteosarcopenia (OR = 0.411, 95% CI: 0.319-0.529)”
Humanspostmenopausal womenfemalesn = 342
Healthcare (Basel, Switzerland)
Osteosarcopenia is associated with body mass index in humans.
“Osteosarcopenia was associated with low BMI, slow gait speed, impaired mobility, impaired ability in the activities of daily living and depression.”
Humansn = 2,142
Osteosarcopenia in Finland: prevalence and associated factors
Archives of osteoporosis
Body mass index is associated with osteosarcopenia in humans (low body mass index in postmenopausal women with osteoporosis).
“Low body mass index seemed to be the strongest factor related to the development of osteosarcopenia”
Humanslow body mass index in postmenopausal women with osteoporosisfemales
PloS one
Fragility fracture
upin humans3upin reviews1OR 3.7
4 studies
Fragility fracture
upin humans3upin reviews1OR 3.7
Osteosarcopenia is linked with a higher risk of fragility fracture in humans (2.92fold higher risk (95% CI 1.29-6.49; p = 0.010)).
“The KTRs with both LMM and osteoporosis had a 2.92fold higher risk of fractures (95% CI 1.29-6.49; p = 0.010) than those without both LMM and osteoporosis.”
Humans5.1 yearsn = 342
American journal of nephrology
Osteosarcopenia is linked with a higher risk of fragility fracture in humans (post-menopausal women) (OR 3.70, 95% CI 1.94-7.04).
“The odds ratios between osteosarcopenia and fragility fractures were 3.70 (95% CI: 1.94-7.04) for osteosarcopenia”
Humanspost-menopausal womenfemalesn = 1,199
International journal of molecular sciences
Osteosarcopenia is associated with fragility fracture in humans (Cross-sectional evidence; comparison with individual components) (OR 3.70; 95% CI 1.94–7.04).
“In cross-sectional designs, osteosarcopenia is more strongly associated with fragility fracture than either of its components (OR 3.70; IC 95 %: 1.94–7.04).”
ReviewCross-sectional evidence; comparison with individual components
Ciencia Latina Revista Científica Multidisciplinar
Osteosarcopenia is associated with fragility fracture.
“Osteosarcopenia is a geriatric syndrome characterized by declines in bone density and microarchitecture and muscle mass and strength, which has gained clinical interest due to its association with falls and fragility fractures.”
Review
Osteosarcopenia: beyond age-related muscle and bone loss
European geriatric medicine
Physical function
downin humans2upin humans1mixedin humans1OR 2.11
4 studies
Physical function
downin humans2upin humans1mixedin humans1OR 2.11
Osteosarcopenia is associated with physical function in humans following TAVR (OR 2.11, 95% CI 1.19-3.74).
“Osteosarcopenia, but not low VBD or PMA alone, was independently associated with 1-year mortality (odds ratio [OR], 3.18; 95% CI, 1.54-6.57) and 1-year worsening disability (OR, 2.11; 95% CI, 1.19-3.74).”
Humansfollowing TAVR1 yearn = 605
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement
JAMA cardiology
Osteosarcopenia is associated with physical function in humans (history of falls and/or fractures) (p<0.001).
“Osteosarcopenia performed worse than osteopenia and osteoporosis in grip strength, gait speed, physical function scores and in multiple gait and balance indices (p<0.001).”
Humanshistory of falls and/or fracturesn = 306
Archives of gerontology and geriatrics
Osteosarcopenia is associated with physical function in humans (requiring support or care).
“Osteosarcopenia was more closely associated with body mass index, support or care level, grip strength, gait speed, skeletal muscle mass index, and Mini Nutritional Assessment-Short Form score than osteopenia or sarcopenia alone.”
Humansrequiring support or caren = 141
Features of older community-dwelling adults with osteosarcopenia requiring support or care
Journal of physical therapy science
Osteosarcopenia is associated with physical function in humans (community-dwelling older adults).
“Osteosarcopenia was associated with worse SPPB, TUG, FSS, limit of stability, and falls and fractures history.”
Humanscommunity-dwelling older adults
Journal of the American Medical Directors Association
Older age
upin humans3OR 1.06–15.4
3 studies
Older age
upin humans3OR 1.06–15.4
Older age is associated with osteosarcopenia in humans (Older Vietnamese outpatients; multivariable analysis) (OR 1.06 per 1-year increase, 95% CI 1.02–1.10).
“older age (per 1-year increase; OR 1.06, 95% CI 1.02-1.10)”
HumansOlder Vietnamese outpatients; multivariable analysisn = 389
PloS one
Older age is associated with osteosarcopenia in humans (acute stroke) (OR 15.4).
“Older age (≥65 yrs) (odds ratio, 15.4), female sex (odds ratio, 6.23), and lower body mass index (<25 kg/m 2 ) (odds ratio, 43.13) were independently associated with the likelihood of osteosarcopenia.”
Humansacute stroken = 224
American journal of physical medicine & rehabilitation
Older age raises the risk of osteosarcopenia in humans (OR 1.12, 95% CI: 1.03-1.21).
“The risk factors for osteosarcopenia were female (OR 5.10, 95% CI: 2.37-10.98), older age (OR 1.12, 95% CI: 1.03-1.21), and fracture (OR 2.92, 95% CI: 1.62-5.25).”
Review
Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis
BMC geriatrics
Inflammation
upin humans1upin reviews1no changein reviews1
3 studies
Inflammation
upin humans1upin reviews1no changein reviews1
Inflammation is associated with osteosarcopenia in humans (history of falls and fractures).
“Osteosarcopenia exhibited unique immune-related profiles distinct from those of sarcopenia and controls”
Humanshistory of falls and fracturesserumn = 50
Cytokine
Inflammation is associated with osteosarcopenia (pathogenesis of osteosarcopenia).
“Multiple pathological processes-including chronic low-grade inflammation, Th17/Treg imbalance, macrophage polarization, oxidative stress, impaired mitophagy, insulin resistance, ectopic fat accumulation, and altered microbial metabolites-may converge to disrupt bone-muscle crosstalk”
Reviewpathogenesis of osteosarcopenia
Metabolites
Inflammation is associated with osteosarcopenia.
“Osteosarcopenia arises from shared pathophysiological mechanisms, including chronic low-grade inflammation, oxidative stress, hormonal changes, and nutritional deficiencies.”
Review
Gerontology
Disability
upin humans3HR 1.73
3 studies
Disability
upin humans3HR 1.73
Osteosarcopenia is linked with a higher risk of disability in humans (HR 1.73, 95% CI 1.43-2.09).
“OS (HR: 1.73, 95% CI: 1.43-2.09) had a higher risk of disability than nonOP/nonSP participants.”
Humans5 yearsn = 8,995
Impact of osteosarcopenia on disability and mortality among Japanese older adults
Journal of cachexia, sarcopenia and muscle
Osteosarcopenia is associated with disability in humans (WHODAS compared with normal, osteopenia-only and sarcopenia-only groups) (WHODAS 17.5 (95% CI: 14.8-20.1) in osteosarcopenia group).
“were statistically significantly higher in the osteosarcopenia group compared the other groups”
HumansWHODAS compared with normal, osteopenia-only and sarcopenia-only groupsn = 885
Disability, Frailty and Depression in the community-dwelling older adults with Osteosarcopenia
BMC geriatrics
Osteosarcopenia is associated with disability in humans (older adults undergoing TAVR) (P < 0.05).
“Combined deficits in muscle and bone health are associated with elevated risks of post-TAVR complications, prolonged hospitalizations, and worsening disability”
Reviewolder adults undergoing TAVR
World journal of cardiology
All 159Fewer
Trial sponsors
Funding
14 grants since 2020Japan Society for the Promotion of Science¥32.9MHealth and Medical Research FundHK$2.7MSwiss National Science FoundationCHF 734K
Elucidation of Novel Signals Inducing Osteosarcopenia
Japan Society for the Promotion of ScienceKindai University¥4.6M2026–2029
São Paulo Research FoundationUniversidade de Santo Amaro2026–2029
Multiparametric Evaluation of osteosarcopeniA diSease Using magnetic Resonance ImagiNG (MEASURING)
Swiss National Science FoundationUniversity of BaselCHF 734K2025–2029
Japan Society for the Promotion of ScienceMie University¥4.7M2025–2030
Multiparametric Evaluation of osteosarcopeniA diSease Using magnetic Resonance ImagiNG
European CommissionAlma Mater Studiorum - Universita di Bologna€173K2025–2027
Health and Medical Research FundChinese University of Hong KongHK$1.2M2023
Japan Society for the Promotion of ScienceUniversity of Hyogo¥4.6M2022–2025
Japan Society for the Promotion of ScienceSapporo Medical University¥4M2022–2026
Quantifying Osteosarcopenia Progression with Imaging Biomarkers in Prostate Cancer
Gouvernement du Canada | Canadian Institutes of Health ResearchSunnybrook Health Science CentreCA$636K2022–2027
The risk factor of Osteosarcopenia in Parkinson's disease patients
Japan Society for the Promotion of ScienceKitasato University¥2.7M2021–2025
How this record changed
Summary rewritten as its findings changed.
As it read before
Human cohorts link osteosarcopenia to higher mortality in community-dwelling older adults and patients undergoing hemodialysis. Human studies also associate it with falls, fractures, frailty, impaired mobility and poorer quality of life, with vertebral fracture risk reported in a longitudinal cohort.
Summary rewritten as its findings changed.
As it read before
A review links low body mass index to higher osteosarcopenia risk and osteosarcopenia to falls in people with type 2 diabetes, while describing no effect of metformin on osteosarcopenia.
Summary written from the findings.